The most consequential APAC biopharma deal of 2026 is Sun Pharma's all-cash agreement to buy Organon, which Sun describes as ...

Agreement links medicine affordability with continued innovation as Astellas commits to internationally aligned pricing for future therapies and donates 25 kg of tacrolimus API to the US Strategic ...

Singapore imaging provider is the earliest site in the region to adopt a new generation of MRI technology. MR31 will enable ...

Sartorius and MAbSilico are collaborating to connect Al-driven protein discovery with automated, high-throughput cell line ...

Suvoda, a global clinical trial technology company, announced a new release of important advancements since unifying the ...

First-in-human study evaluates dual-target, dual-payload ADC in advanced ovarian cancer and other solid tumours Phrontline ...

Rznomics Inc., a biopharmaceutical company specializing in the development of RNA-based gene therapies, announced that the ...

Sixty-four discontinued programmes, withdrawn filings, lapsed deals and missed dates from Asia-Pacific sponsors, each one sourced to the sponsor's own disclosure. Most of them came with a strategy, ...

In TRIUMPH-2, participants with obesity and type 2 diabetes taking retatrutide 12 mg lost an average of 49.6 lbs (20.8%) over ...

FDA Fast Track designation granted for Telix's BiPASS® program, which is evaluating 68Ga-PSMA-PET imaging alongside MRI in ...

Researchers will gain an integrated synthetic data foundation and an advanced custom search platform to support reaction data ...

Piramal Pharma Solutions is investing over $5.3 million in its Aurora drug substance facility to upgrade site infrastructure.